LicianPro

Tonix Pharmaceuticals Holding Corp. ·

TNXP 8-K 2026-10-02

Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K dated 2026-10-02 — accession 0001493152-26-045603.

Tonix Pharmaceuticals Holding Corp. (TNXP) is a biotechnology company listed on NASDAQ.

Tonix Pharmaceuticals Holding Corp. filed a 8-K on 2026-10-02. Accession 0001493152-26-045603.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported TNXP revenue for 2025-12-31 was $13.1M. Net income was -$124.0M. Revenue was up 29.8% from 2024-12-31 to 2025-12-31. TNXP currently screens at market cap $194.5M.

Not investment advice. The TNXP SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr